Supriya Lifescience IPO opened for subscription on 16th December 2021 and it will remain open for bidding till 20th December 2021.
Ankur Saraswat, Research Analyst at Trustline Securities said, “Company is one of the leading API manufacturers and largest exporters of HCL and Salbutamol Sulphate in India.